Skip to main content
Fig. 2 | Allergy, Asthma & Clinical Immunology

Fig. 2

From: Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers

Fig. 2

Time course of MP-AzeFlu effects on HECM-induced eosinophil survival. HECM at 10% from nasal mucosa (black circles) significantly increased eosinophil survival compared with control medium (white circles) from days 1 to 4. MP-AzeFlu (grey circles) at dilution 1:102 significantly decreased eosinophil survival induced by HECM from days 2 to 4. Results are expressed as mean ± SEM percentage of eosinophil survival compared with HECM. ANOVA with the Dunnett multiple comparison test was used for analysis (N = 7). *P < 0.05; ***P < 0.001 compared with HECM. ANOVA analysis of variance, HECM human epithelial cell–conditioned media, MP-AzeFlu intranasal azelastine hydrochloride and intranasal fluticasone propionate in a single device. SEM standard error of the mean

Back to article page